Cargando…
Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
BACKGROUND: Inflammatory bowel diseases (IBDs) are chronic diseases that demand continuous interaction between patients and healthcare providers. Quality of care (QoC) is a factor that contributes to a patient’s adherence to treatment and its success. AIM: To evaluate QoC in patients from a single I...
Autores principales: | Takamune, Debora Mayumi, Cury, Giovana Signorelli Astolfi, Ferrás, Giulia, Herrerias, Giedre Soares Prates, Rivera, Adriana, Barros, Jaqueline Ribeiro, Baima, Julio Pinheiro, Saad-Hossne, Rogerio, Sassaki, Ligia Yukie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724505/ https://www.ncbi.nlm.nih.gov/pubmed/36483811 http://dx.doi.org/10.12998/wjcc.v10.i33.12184 |
Ejemplares similares
-
Clinical and Psychological Factors Associated with Addiction and Compensatory Use of Facebook Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Study
por: Cury, Giovana Signorelli Astolfi, et al.
Publicado: (2022) -
Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021) -
Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021) -
Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020) -
Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)